1) In Vivo Confocal Microscopy of the Corneal Sub-Basal Nerve plexus in Medically Controlled Glaucoma.

Agnifili L., Brescia L., Villani E., D’Onofrio G., Figus M., Oddone F., Nucci P., Mastropasqua R.

Microsc Microanal. PMID: 34991750 DOI: 10.1017/S1431927621013969

2) Introductory remarks.

Ascenzi P., Bellelli A., Coletta M.

Mol Aspects Med. PMID 35022137. https://doi.org/10.1016/j.mam.2022.101065

3) Cochrane Corner: evidence on the management of primary angle closure glaucoma

Michelessi M., Azuara-Blanco A., Virgili G.

Eye (Lond). PMID 35031705 . DOI: 10.1038/s41433-021-01848-9

4) Sustained release glaucoma therapies: Novel modalities for overcoming key treatment barriers associated with topical medications.

Belamkar A., Harris A., Zukerman R., Siesky B., Oddone F., Verticchio Vercellin A., Ciulla TA.

Ann Med. 2022 ;54(1):343-358.doi: 10.1080/07853890.2021.1955146.

5) Glaucoma Treatment Outcomes in Open-Angle Glaucoma Patients of African Descent.

Siesky B., Harris A., Belamkar A., Zukerman R., Horn A., Vercellin AV., Mendoza KAV., Sidoti PA, Oddone F.

J Glaucoma. 2022 Mar 29. doi: 10.1097/IJG.0000000000002027. Online ahead of print.

6) Choroidal Thickness and Primary Open-Angle Glaucoma-A Narrative Review.

Alice Verticchio Vercellin, Alon Harris, Ari M. Stoner, Francesco Oddone, Kristen Ann Mendoza and Brent Siesky

J Clin Med. 2022 feb 23;11(5):1209. Doi: 10.3390/jcm11051209

7) Neuroprotective Effect of Carnosine Is Mediated by Insulin-Degrading Enzyme”.

Distefano A., Caruso G., Oliveri V., Bellia F., Sbardella D., Zingale GA, Caraci F., Grasso G.

ACS Chem Neurosci. 2022 May 18;13(10):1588-1593.doi: 10.1021/acschemneuro.2c00201. Epub 2022 Apr 26.

8) “Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment”.

Oddone F., Kirwan J., Lopez-Lopez F., Zimina M., Fassari C., Holló G.; VISIONARY Study Group.

Adv Ther. 2022 May 7.doi: 10.1007/s12325-022-02166-6. Online ahead of print.

9) “Hydroxylamine-induced oxidation of ferrous nitrobindins”.

De Simone G., Tundo GR (problema doppia affiliazione), Coletta A., Coletta M, Ascenzi P.

J Biol Inorg Chem. 2022 May 11.doi: 10.1007/s00775-022-01940-9. Online ahead of print.

10) “Asian Race and Primary Open-Angle Glaucoma: Where Do We Stand?”

Belamkar A., Harris A., Oddone F., Verticchio Vercellin A., Fabczak-Kubicka A., Siesky B.

J Clin Med. 2022 Apr 28;11(9):2486. doi: 10.3390/jcm11092486.

11) “Silybins are stereospecific regulators of the 20S proteasome”.

Persico M., García-Viñuales S., Santoro AM, Lanza V., Tundo GR, Sbardella D., Coletta M., Romanucci V., Zarrelli A., Di Fabio G., Fattorusso C., Milardi D.

Bioorg Med Chem. 2022 Jul 15;66:116813.doi: 10.1016/j.bmc.2022.116813. Epub 2022 May 10.

12) “A comparison of country-level data from the VISIONARY study examining treatment outcomes with preservative-free tafluprost/timolol fixed-dose combination therapy”.

Holló G., Kirwan J., Lopez-Lopez F., Zimina M., Fassari C., Oddone F.; VISIONARY study group.

Curr Med Res Opin. 2022 Jun 9;1-13.doi: 10.1080/03007995.2022.2083324. Online ahead of print

13) “The current use of glaucoma virtual clinics in Europe.”

Azzopardi M., Prokosch-Willing V., Michelessi M., Fea AM, Oddone F., Mercieca K.

Eye (Lond). 2022 Jun 11;1-7.doi: 10.1038/s41433-022-02111-5. Online ahead of print.

14) Modulation of the 20S Proteasome Activity by Porphyrin Derivatives Is Steered through Their Charge Distribution”

Persico M., Santoro A. M. , D’Urso A. , Milardi D., Purrello R., Cunsolo A., Gobbo M., Fattorusso R., Diana D., Stefanelli M., Sbardella D. , Coletta M. , Fattorusso C.

Biomolecules. 2022 May 24;12(6):741. doi: 10.3390/biom12060741.

15) “Dissociation of the proximal His-Fe bond upon NO binding to ferrous zebrafish nitrobindin”

De Simone G., Fattibene P. ,Sebastiani F., Smulevich G., Coletta M., Ascenzi P.

J Inorg Biochem.2022 Nov;236:111962. doi: 10.1016/j.jinorgbio.2022.111962. Epub 2022 Aug 17.

16) “Nitrosylation of ferric zebrafish nitrobindin: A spectroscopic, kinetic, and thermodynamic study”

De Simone G., Sebastiani F., Smulevich G., Coletta M., Ascenzi P.

J Inorg Biochem. 2022 Sep 15;237:111996. doi: 10.1016/j.jinorgbio.2022.111996. Online ahead of print.

17) “Italian Candidates for the XEN Implant: An Overview from the Glaucoma Treatment Registry (XEN-GTR)”

Posarelli C., Figus M., Roberti G., Giammaria S., Ghirelli G., Quercioli P., Micelli Ferrari, Pace V., Mastropasqua L., Agnifili L., Sacchi M., Scuderi G. , Perdicchi A., Altafini R., Uva M., D’Andrea D., Covello G., Maglionico M. N., Fea A. M., Carnevale C., Oddone F.

J Clin Med. 2022 Sep 9;11(18):5320. doi: 10.3390/jcm11185320.

18) “Glaucoma Progression Diagnosis: The Agreement between Clinical Judgment and Statistical Software”

Roberti G., Michelessi M., Tanga L., Belfonte L., Del Grande L. M., Bruno M., Oddone F.

Clin. Med. 2022, 11(19), 5508; https://doi.org/10.3390/jcm11195508

19) “The Balancing of Peroxynitrite Detoxification between Ferric Heme-Proteins and CO2: The Case of Zebrafish Nitrobindin”

De Simone G., Coletta A., Di Masi A., Coletta M., Ascenzi P.

Antioxidants2022, 11(10), 1932;https://doi.org/10.3390/antiox11101932

20) “Citicoline Eye Drops Protect Trabecular Meshwork Cells from Oxidative Stress Injury in a 3D In Vitro Glaucoma Model.”

Vernazza S. , Passalacqua M., Tirendi S., Marengo B., Domenicotti C., Sbardella D., Oddone F., Bassi A. M.

International Journal of molecular science Int J Mol Sci 2022 Sep 27;23(19):11375. doi: 10.3390/ijms231911375.

21) Reviewing the evidence surrounding preservative-free tafluprost/timolol fixed-dose combination therapy in open angle glaucoma and ocular hypertension management: a focus on efficacy, safety and tolerability

Oddone F.

Expert Opin Drug Saf 2022 Oct;21(10):1259-1268.doi: 10.1080/14740338.2022.2135701. Epub 2022 Oct 26.

22) Assessment of a Vision-Based Technique for an Automatic Van Herick Measurement System

Fedullo T., Cassanelli D., Gibertoni G., Tramarin F., Quaranta L., Riva I., Tanga L., Oddone F., Rovati L.

IEEE Transactions on Instrumentation and Measurement, vol. 71, pp. 1-11, 2022, Art no. 2516111, doi: 10.1109/TIM.2022.3196323.

23) Detecting glaucoma from multi-modal data using probabilistic deep learning.

Huang X., Sun J., Gupta K., Montesano G., Crabb D.P., Garway-Heath D.F., Brusini P., Lanzetta P., Oddone F., Turpin A., McKendrick A.M., Johnson C.A., Yousefi S.

Front Med (Lausanne) 2022 Sep 29;9:923096. doi: 10.3389/fmed.2022.923096. eCollection 2022.

24) Targeting immunoproteasome in neurodegeneration: a glance to the future.

Tundo G. R., Cascio P., Milardi D., Santoro A.M., Graziani G., Lacal P.M., Bocedi A., Oddone F., Parravano M., Coletta A., Coletta M., Sbardella D.

Pharmacology & Therapeutics,2022,108329,ISSN 0163-7258, https://doi.org/10.1016/j.pharmthera.2022.108329.

25) “Efficacy of Nonpreserved Sodium Hyaluronate Artificial Tears in Dry Eye Disease Patients Treated with Prostaglandin Analogs for Primary Open-Angle Glaucoma: A Prospective,Nonrandomized, Open-Label Pilot Study”.

Coco G., Iannetta D., Febbraro I., Elmo E., Manni G.

J Ophthalmol. 2022 Dec 2;2022:1320996. doi: 10.1155/2022/1320996. eCollection 2022.

26) Disease Progression Pathways of Wet AMD: Opportunities for New Target Discovery.

Wolf AT., Harris A., Oddone F., Siesky B., Verticchio Vercellin A., Ciulla T.A.

Expert Opin Ther Targets 2022 Jan;26(1):5-12.doi: 10.1080/14728222.2022.2030706. Epub 2022 Feb 23.

27) “Structural and (Pseudo-)Enzymatic Properties of Neuroglobin: Its Possible Role in Neuroprotection”

De Simone G., Sbardella D., Oddone F., Pesce A., Coletta M., Ascenzi P.

Cells 2021, 10(12), 3366; https://doi.org/10.3390/cells10123366

28) ”Treatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy.”

Oddone F., Scorcia V., Iester M., Sisto D., De Cilla S., Bettin P., Cagini C., Figus M, Marchini G, Rossetti L., Rossi G, Salgarello T., Scuderi GL, Staurenghi G.; VISIONARY Study Group (Italy).

Clin Ophthalmol. 2022 Jun 1;16:1707-1719. doi: 10.2147/OPTH.S364880. eCollection 2022.

29) ”Rates of Visual Field Change in Patients With Glaucoma and Healthy Individuals—Findings From a Median 25-Year Follow-up—Reply”

Giammaria S., Chauhan Balwantray C.

JAMA Ophthalmol. Published online September 29, 2022. doi:10.1001/jamaophthalmol.2022.323

1) Comparison of different methods to calculate the axial length measured by optical biometry.

Savini G., Hoffer K.J., Carballo L., Taroni L., Schiano-Lomoriello D.

J Cataract Refract Surg. 2021 Sep 20. doi: 10.1097/j.jcrs.0000000000000821. Online ahead of print.

2) Comparison of a New Optical Biometer That Combines Scheimpflug Imaging With Partial Coherence Interferometry With That of an Optical Biometer Based on Swept-Source Optical Coherence Tomography and Placido-Disk Topography.

Chen S., Zhang Q., Savini G., Zhang S., Huang X., Yu J., Wang Y., Ning R., Huang J., Tu R.

Front Med (Lausanne). 2022 Feb 10;8:814519. doi: 10.3389/fmed.2021.814519. eCollection 2021

3) Intraocular lens power calculation with ray tracing based on AS-OCT and adjusted axial length after myopic excimer laser surgery.

Savini G., Hoffer K.J., Ribeiro FJ, Dias JM, Coutinho CP, Barboni P., Lomoriello DS.

J Cataract Refract Surg. 2022 Feb 2. doi: 10.1097/j.jcrs.0000000000000902. Online ahead of print.

4) “Corneal diameter measurements by 3 optical biometers and their effect on phakic intraocular lens sizing”.

Savini G., Lupardi E., Hoffer KJ, Aramberri J., Schiano-Lomoriello D.

J Cataract Refract Surg. 2022 May 26.doi: 10.1097/j.jcrs.0000000000000976. Online ahead of print.

5) “Agreement Between Predicted and Actual Measured Ablation Depth After FS-LASIK Using Different Rotating Scheimpflug Cameras and OCT”.

Chen H., Wang Z., Li K., Wang Y., Li X., Du L., Lin M., Savini G., Wang Q., Yu A., Chen S.

Front Med (Lausanne). 2022 May 19;9:907334. doi: 10.3389/fmed.2022.907334.

6) “Repeatability of new optical biometer and agreement with two validated optical biometers, all based on swept-source optical coherence tomography”

Galzignato A. , Lupardi E., Hoffer K.J., Piero Barboni, Schiano Lomoriello, Giacomo Savini

J Cataract Refract Surg. 2022 Aug 23.doi: 10.1097/j.jcrs.0000000000001023. Online ahead of print

7) “IOL Power Calculation in Eyes Undergoing Combined Descemet Membrane Endothelial Keratoplasty and Cataract Surgery”

Knutsson K. A., Savini G., Hoffer K. J., Lupardi E., Bertuzzi F., Taroni L., Schiano-Lomoriello D., Paganoni G., Rama P.

J Refract Surg. 2022 Jul;38(7):435-442. doi: 10.3928/1081597X-20220601-02. Epub 2022 Jul 1.

8) Optical biometry and IOL calculation in a commercially available optical coherence tomography device and comparison with Pentacam AXL.

Kanclerz P., Hoffer K. J., Bazylczyk N., Wang X., Savini G.

Am J Ophthalmol. 2022 Oct 14;246:236-241. doi: 10.1016/j.ajo.2022.09.022. Online ahead of print.

9)Comparison of the New Hoffer QST with 4 Modern Accurate Formulas.

Taroni L., Hoffer K.J., Pellegrini MK, Lupardi E., Savini G.

Journal of Cataract & Refractive Surgery ():10.1097/j.jcrs.0000000000001126, December 16, 2022. | DOI: 10.1097/j.jcrs.0000000000001126

10) “Reply: Intraocular lens power calculation with ray tracing based on AS-OCT and adjusted axial length after myopic excimer laser surgery”

Savini G., Hoffer K. J., Facs F., Ribeiro F., Dias, J M, Coutinho C., Barboni P., Schiano-Lomoriello D.

J Cataract Refract Surg. 2022 Sep 6.doi: 10.1097/j.jcrs.0000000000001056. Online ahead of print

11) ”Reply: Comparison of different methods to calculate the axial length measured by optical biometry”

Savini G., Hoffer K. J., Carballo L., Taroni L., Schiano-Lomoriello D.

J Cataract Refract Surg. 2022 Aug 1;48(8):978-979. doi: 10.1097/j.jcrs.0000000000000994

1) Update on Current and Future Management for Diabetic Maculopathy.

Patricia Udaondo; Mariacristina Parravano; Stela Vujosevic; Dinah Zur; Usha Chakravarthy.

Ophthalmol Ther. 2022 Apr;11(2):489-502. doi: 10.1007/s40123-022-00460-8. Epub 2022 Jan 31.

2) Optical Coherence Tomography Angiography In Central Retinal Vein Occlusion: Macular Changes And Their Correlation With Peripheral Nonperfusion At Ultra-Widefield Fluorescein Angiography.

Michele Cavalleri, Riccardo Sacconi, Mariacristina Parravano, Eliana Costanzo, Mario Pezzella, Francesco Bandello, Giuseppe Querques

Ophthalmologica. 2022 Feb 10. doi: 10.1159/000522503. Online ahead of print.

3)Choroidal Caverns in Stargardt Disease.

Mucciolo D.P., Giorgio D., Lippera M., Dattilo V., Passerini I., Pelo E., Sodi A., Virgili G., Giansanti F., Murro V.

Invest Ophthalmol Vis Sci. 2022 Feb 1;63(2):25. doi: 10.1167/iovs.63.2.25.

4) A common finding in foveal-sparing extensive macular atrophy with pseudodrusen (EMAP) implicates basal laminar deposits.

Serena Fragiotta, Mariacristina Parravano, Riccardo Sacconi, Eliana Costanzo, Pasquale Viggiano, Francesco Prascina, Vittorio Capuano, Giuseppe Querques.

Retina: February 21, 2022 doi: 10.1097/IAE.0000000000003463

5) Discerning Between Macular Hemorrhages Due to Macular Neovascularization or Due to Spontaneous Bruch’s Membrane Rupture in High Myopia: A Comparative Analysis Between OCTA and Fluorescein Angiography.

Battista M., Sacconi R., Borrelli E., Crepaldi A., Fantaguzzi F., Costanzo E., De Geronimo D., Parravano M., Bandello F., Querques G.

Ophthalmol Ther. 2022 Apr;11(2):821-831. doi: 10.1007/s40123-022-00484-0. Epub 2022 Feb 20.

6) Functional Correlates of Outer Retina Remodeling in Intermediate Age-Related Macular Degeneration Using Microperimetry.

Fragiotta S., Costanzo E., Viggiano P., De Geronimo D., Scuderi G., Varano M., Parravano M.

Invest Ophthalmol Vis Sci. 2022 Mar 2;63(3):16. doi: 10.1167/iovs.63.3.16.

7) “Choroidal modifications assessed by means of choroidal vascularity index after oral eplerenone treatment in chronic central serous chorioretinopathy”.

Toto L., Ruggeri M.L., Evangelista F., Viggiano P., D’Aloisio R., De Nicola C., Falconio G., Di Nicola M., Porreca A., Mastropasqua R.

Eye (London). 2022 May 19. doi: 10.1038/s41433-022-02091-6. Online ahead of print.

8) “Economic Aspects in the Management of Diabetic Macular Edema in Italy”

Calabrò G.E., Basile M., Varano M., Amore F., Ricciardi R., Bandello F., Cicchetti A.

Front Public Health. 2022 Jul 22;10:938987.doi: 10.3389/fpubh.2022.938987. eCollection 2022

9) “Optical Coherence tomography angiography characterization of evolving lesions in fellow eyes of exudative type 3 MNV patients”

Sacconi R., Forte P., Capuano V., Miere A., Costanzo E., Tombolini B., Fantaguzzi F., Jung C., Parravano M., Varano M., Souied E., Bandello F., Queques G.

Retina2022 Aug 12.doi: 10.1097/IAE.0000000000003598. Online ahead of print.

10) “In vivo assessment of associations between photoreceptors structure and macular perfusion in type 1 diabetes”

Viggiano P., Costanzo E., Giannini D., Fragiotta S., De Geronimo D., Giorno P., Picconi F., Frontoni S., Varano M., Parravano M.

Br J Ophthalmol. 2022 Sep 1;bjophthalmol-2022-321617.doi: 10.1136/bjo-2022-321617. Online ahead of print

11) “Towards a better understanding of non-exudative choroidal and macular neovascularization”

Sacconi R, Fragiotta S, Sarraf D, Sadda S R, Freund K Bailey, Parravano M, Corradetti G, Cabral D, Capuano V, Miere A, Costanzo E, Bandello F, Souied E, Querques G.

Prog Retin Eye Res. 2022 Aug 13;101113. doi: 10.1016/j.preteyeres.2022.101113. Online ahead of print

12) “Impact of Intravitreal Anti-VEGF Therapy on Microperimetry of the Retinal Nonperfusion Areas of Patients with Proliferative Diabetic Retinopathy”

Parravano M., De Geronimo D., Sacconi R., Giannini D., Costanzo E., Fragiotta S., Viggiano P., Querques G.

Ophthalmol Ther. 2022 Sep 17. doi: 10.1007/s40123-022-00568-x. Online ahead of print.

13) “Sub-retinal pigment epithelium tubules in non-neovascular age-related macular degeneration”

Fragiotta S., Parravano M., Sacconi R., Costanzo E., De Geronimo D., Prascina F., Capuano V., Souied E. H., Han I. C, Mullins R., Querques G.

Sci Rep. 2022 Sep 7;12(1):15198.doi: 10.1038/s41598-022-19193-6.

14) “Retinal Pigment Epithelium Atrophy after subretinal Voretigene Neparvovec-rzyl for RPE65-related disease: a 6-month follow-up”

Giansanti F., Mucciolo D. P., Sodi A., Giorgio D., Virgili G., Murro V.

Retina 2022 Sep 2.doi: 10.1097/IAE.0000000000003576. Online ahead of print.

15) “Relative ellipsoid zone reflectivity and its association with disease severity in age-related macular degeneration: a MACUSTAR study report”

Saßmannshausen M., Behning C., Isselmann B., Schmid M., Finger R.F. , Holz F.G., Schmitz-Valckenberg S., Pfau M., MACUSTAR Consortium; Thiele S.

Sci Rep. 2022 Sep 2;12(1):14933.doi: 10.1038/s41598-022-18875-5.

16) Ocular biomarkers for Alzheimer’s Disease Dementia: An Umbrella Review of Systematic Reviews and Meta-analyses

Costanzo E., Lengyel I., Parravano M., Biagini I., Veldsman M, Badhwar A., Betts M., Cherubini A., Llewellyn DJ, Lourida I., MacGillivray T., Rittman T., Tamburin S., Tai XY, Virgili G.

JAMA Ophthalmol. 2022 Nov 17. doi: 10.1001/jamaophthalmol.2022.4845. Online ahead of print.

17) The state-of-the-art pharmacotherapeutic management of neovascular age-related macular degeneration

Servillo A., Zucchiatti I., Sacconi R., Parravano M., Querques L,, La Rubia P,, Prascina F,, Bandello F,, Querques G.

Expert Opin Pharmacother. 2022 Dec 5;1-10. doi: 10.1080/14656566.2022.2154145. Online ahead of print.

18) “Effect of intravitreal dexamethasone implant in treatment-naive and previously-treated patients with diabetic macular edema.

Nikolopoulou E., Sacconi R., Lorusso M., Costanzo E., Parravano M., Micelli Ferrari L., Ferrari TM., Querques G.

Eur J Ophthalmol 2022 Dec 1;11206721221143166. doi: 10.1177/11206721221143166. Online ahead of print.

19) The Association between vision impairment and depression: a systematic review of population-based studies

Virgili G., Parravano M., Petri D., Maurutto E., Menchini F., Lanzetta P., Varano M., Mariotti SP., Cherubini A., Lucenteforte E.

J Clin Med 2022 Apr 25;11(9):2412. doi: 10.3390/jcm11092412.

20) “Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials”.

Heier J. S., Khanani A. M., Quezada Ruiz C., Basu K., Ferrone P. J., Brittain C., Figueroa M .S., Lin H., Holz F G., Patel V., Lai T. Y .Y., Silverman D., Regillo C., Swaminathan B., Viola F., Cheung C .M .G., Wong T. Y., TENAYA and LUCERNE Investigators.

Lancet. 2022 Feb 19;399(10326):729-740. doi: 10.1016/S0140-6736(22)00010-1. Epub 2022 Jan 24.

21) ”Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials”

Wykoff CC, Abreu F., Adamis AP, Basu K., Eichenbaum DA, Haskova Z., Lin H., Loewenstein A., Mohan S., Pearce IA, Sakamoto T., Schlottmann PG, Silverman D., Sun JK, Wells JA, Willis JR, Tadayoni R.; YOSEMITE and RHINE Investigators

Lancet. 2022 Feb 19;399(10326):741-755. doi: 10.1016/S0140-6736(22)00018-6. Epub 2022 Jan 24.

22) ”Disease-specific assessment of Vision Impairment in Low Luminance in age-related macular degeneration – a MACUSTAR study report”.

Jan Henrik Terheyden , Susanne G Pondorfer , Charlotte Behning , Moritz Berger , Jill Carlton , Donna Rowen, Christine Bouchet , Stephen Poor , Ulrich F O Luhmann, Sergio Leal , Frank G Holz , Thomas Butt , John E Brazier , Robert P Finger , MACUSTAR consortium

Br J Ophthalmol. 2022 Mar 30;bjophthalmol-2021-320848. doi: 10.1136/bjophthalmol-2021-320848. Online ahead of print.

1) ”Human Vitreous Collagen Fragments Dimension As a Function of Vitrectomy Cut Rate”.

Rossi T., Speciale A., Menichini P., Izzotti A., D’Agostino I., Trillo C., Telani S., Querzoli G., Ripandelli G.

Transl Vis Sci Technol. 2022 Mar 2;11(3):29.doi: 10.1167/tvst.11.3.29.

2) “Comparative Evaluation of Antimicrobial, Antiamoebic, and Antiviral Efficacy of Ophthalmic Formulations.”

Caruso C., Eletto D., Tosco A., Pannetta M, Scarinci F, Troisi M, Porta A.

Microorganisms. 2022 Jun 4;10(6):1156. doi: 10.3390/microorganisms10061156.PMID: 35744674

3) ”Silicone Oil Tamponade-Retina Contact in Highly Myopic Eyes With and Without Encircling Bands: A Computational Fluid Dynamics Study”.

Rossi T., Querzoli G., Badas MG, Angius F., Ripandelli G.

4) Transl Vis Sci Technol2022 Jun 1;11(6):1.doi: 10.1167/tvst.11.6.1.4) Comparison of retrobulbar, sub-tenon anesthesia and medial canthus episcleral anesthesia for 25-cauge posterior vitrectomy.

Roman-Pognuz D., Scarpa G., Virgili G., Roman-Pognuz E., Paluzzano G., Cavarzeran F.

Retina 2022 Jan 1;42(1):19-26. doi: 10.1097/IAE.0000000000003260.

5) “Bilateral optic neuritis as the presenting sign of post SARS-CoV-2 acute disseminated encephalomyelitis”.

Rossi T., Novi G., D’Agostino I., Di Cello L., Soldati M. R., Telani S., Ripandelli G.

Am J Ophthalmol Case Rep. 2022 Mar;25:101273. Doi: 10.1016/j.ajoc.2022.101273.Epub 2022 Feb 4

6) “Superficial and Deep Capillary Plexuses: Potential Biomarkers of Focal Retinal Defects in Eyes Affected by Macular Idiopatic Epiretinal Membranes? A Pilot Study”

Coppe A.M., Lapucci G., Buzzonetti L., Ripandelli G., Iarossi G.

Diagnostics (Basel). 2022 Dec 17;12(12):3205.doi: 10.3390/diagnostics12123205.

1) Choroidal Abnormalities in Pediatric NF1: A Cohort Natural History Study

Eleonora Cosmo, Luisa Frizziero, Giacomo Miglionico, Chiara Sofia De Biasi, Marisa Bruno, Eva Trevisson, Ilaria Gabbiato, Giulia Midena, Raffaele Parrozzani.

Cancers (Basel). 2022 Mar 10;14(6):1423. doi: 10.3390/cancers14061423.

2) Case Report: Multiple Retinal Astrocytic Hamartomas in Congenital Disorder of Glycosylation-Ia.

Midena G., Pilotto E.

Front Med (Lausanne). 2022 Feb 14;9:697030. doi: 10.3389/fmed.2022.697030. eCollection 2022

3) Small Fibre Peripheral Alterations Following COVID-19 detected by Corneal Confocal Microscopy.

Edoardo Midena, Eleonora Cosmo, Anna Maria Cattelan, Chiara Briani, Davide Leoni, Alfio Capizzi, Vanessa Tabacchi, Raffaele Parrozzani, Giulia Midena and Luisa Frizziero.

Pers. Med. 2022, 12(4), 563; https://doi.org/10.3390/jpm12040563

4) Response to comment on “Intraocular fluid biomarkers (liquid biopsy) in human diabetic retinopathy.”

Midena E., Frizziero L., Midena G., Pilotto E.

Graefes Arch Clin Exp Ophthalmol. 2022 Mar;260(3):1041-1042.doi: 10.1007/s00417-021-05463-y.

5) Handheld Fundus Camera for Diabetic Retinopathy Screening: A Comparison Study with Table-Top Fundus Camera in Real-Life Setting.

Midena E., Zennaro L., Lapo C., Torresin T., Midena G., Pilotto E., Frizziero L.

J Clin Med. 2022 Apr 22;11(9):2352. doi: 10.3390/jcm11092352.

6) Retinal Microvascular and Neuronal Changes Are Also Present, Even If Differently, in Adolescents with Type 1 Diabetes without Clinical Diabetic Retinopathy2

Pilotto E., Torresin T., Leonardi F., De Rubalcava Doblas , Midena G., Moretti C., Midena E.

J Clin Med. 2022 Jul 8;11(14):3982.doi: 10.3390/jcm11143982.

7) “Hyper-reflective retinal foci as possible in vivo imaging biomarker of microglia activation in von Hippel-Lindau disease”

Pilotto E., Torresin T., Bacelle M. L., De Mojà G., Ferrara A M., Zovato S., Midena G., Modena E.

PLoS One. 2022 Aug 12;17(8):e0272318.doi: 10.1371/journal.pone.0272318. eCollection 2022.

8) “Proptosis secondary to bilateral extraocular muscle enlargement in Noonan syndrome with hypertrophic cardiomyopathy: A case report”

Marchione G., Pilotto E., Midena G.

Eur J Ophthalmol. 2022 Sep 5;11206721221125035.doi: 10.1177/11206721221125035. Online ahead of print.

.

9) “Corneal Confocal Microscopy as a Quantitative Imaging Biomarker of Diabetic Peripheral Neuropathy: A Review”

Cosmo E., Midena G., Frizziero L., Bruno M., Cecere M., Midena E.

J Clin Med 2022 Aug 31;11(17):5130. doi: 10.3390/jcm11175130

10) Determinants of Long-Term Survival in Metastatic Choroidal and Ciliary Body Melanoma: Long-Term Survival in Metastatic Ciliochoroidal Melanoma.

Rantala E.S., Parrozzani R., Hernberg M.M., Chiarion-Sileni V., Kivelä T.T., Midena E.

Am J Ophthalmol. 2022 Nov 1;246:258-272 doi: 10.1016/j.ajo.2022.10.017. Online ahead of print.

11) Ultra-wide-field fundus photography compared to ophthalmoscopy in diagnosing and classifying major retinal diseases.

Midena E., Marchione G., Di Giorgio S., Rotondi G., Longhin E., Frizziero L., Pilotto E., Parrozzani R., Midena G.

Sci Rep 2022 Nov 11;12(1):19287.doi: 10.1038/s41598-022-23170-4.

1) Bimodal sensory integration in migraine: A study of the effect of visual stimulation on somatosensory evoked cortical responses.

Sebastianelli G., Abagnale C., Casillo F., Cioffi E., Parisi V., Di Lorenzo C., Serrao M., Porcaro C., Schoenen J., Coppola G.

Cephalalgia, February 15, 2022 Research Articlehttps://doi.org/10.1177/03331024221075073

2) Genetic characteristics of 234 Italian patients with macular and cone/cone-rod dystrophy. Falsini B., Placidi G., De Siena E., Chiurazzi P., Minnella A.M., Savastano M.C., Ziccardi L., Parisi V., Iarossi G., Percio M., Piteková B., Marceddu G., Maltese P.E., Bertelli M.

Sci Rep. 2022 Mar 8;12(1):3774. doi: 10.1038/s41598-022-07618-1

3) “The pattern of retinal ganglion cell loss in Wolfram syndrome is distinct from mitochondrial optic neuropathies”.

Barboni P., Amore G., Cascavilla M.L., Battista M., Frontino G., Romagnoli M., Caporali L., Baldoli C., Gramegna L.L., Sessagesimi E., Bonfanti R., Romagnoli A., Scotti R., Brambati M., Carbonelli M., Starace V, Fiorini C, Panebianco R., Parisi V., Tonon C., Bandello F, Carelli V., La Morgia C.

Am J Ophthalmol.2022 Apr 19;S0002-9394(22)00119-2.doi: 10.1016/j.ajo.2022.03.019. Online ahead of print

4) “Visual system abnormalities in a case of non-syndromic, complete, isolated corpus callosum agenesis”.

Barbano L., Ziccardi L., Antonelli G., Tinelli E., Parisi V.

J Neurophthalmol.

5) “Capturing the pattern of transition from carrier to affected in Leber’s hereditary optic neuropathy”.

Carbonelli M., La Morgia C., Romagnoli M., Amore G., D’Agati P., Valentino M.L., Caporali L., Cascavilla M.L., Battista M., Borrelli E., Di Renzo A., Parisi V., Balducci N., Carelli V., Barboni P.

Am J Ophthalmol.2022 May 2;241:71-79.doi: 10.1016/j.ajo.2022.04.016. Online ahead of print.

6) “The monoclonal CGRP-receptor blocking antibody erenumab has different effects on brainstem and cortical sensory-evoked responses”.

Casillo F., Sebastianelli G., Di Renzo A., Cioffi E., Parisi V., Di Lorenzo C., Serrao M., Coppola G.

Cephalalgia. 2022 May 30;3331024221103811.doi: 10.1177/03331024221103811.

7) “Multifocal Electroretinogram Photopic Negative Response: A Reliable Paradigm to Detect Localized Retinal Ganglion Cells’ Impairment in Retrobulbar Optic Neuritis Due to Multiple Sclerosis as a Model of Retinal Neurodegeneration”.

Barbano L., Ziccardi L* , Antonelli G., Nicoletti CG, Landi D, Mataluni G., Falsini B , Marfia,GA Centonze D, Parisi V.

Diagnostics (Basel). 2022 May 6;12(5):1156.doi: 10.3390/diagnostics12051156.

8) “Visual stimulation and frequency of focal neurological symptoms engage distinctive neurocognitive resources in migraine with aura patients: a study of resting-state functional networks”

Coppola G., Corbelli I., Di Renzo A., Chiappiniello A., Chiarini P., Parisi V., Guercini G., Calabresi P., Tarducci R., Sarchielli P.

J Headache Pain. 2022 Jul 12;23(1):80. doi: 10.1186/s10194-022-01446-4.

9) “A Hypothalamic Mechanism Regulates the Duration of a Migraine Attack: Insights from Microstructural and Temporal Complexity of Cortical Functional Networks Analysis”.

Porcaro C., Di Renzo A., Tinelli E., Parisi V., Di Lorenzo C., Caramia F., Fiorelli M., Giuliani G., Cioffi E., Seri S., Di Piero V., Pierelli F., Di Lorenzo G., Coppola G.

Int J Mol Sci. 2022 Oct 31;23(21):13238. doi: 10.3390/ijms232113238.

10) Childhood-Onset Leber Hereditary Optic Neuropathy – Clinical and Prognostic Insights

Barboni P., La Morgia C., Cascavilla ML, Hong EH, Basstista M, Maiander A, Caporali L, Starace V, Amore G., Di renzo A., Carbonelli M, Nucci P., Jurkute N, Benson S Chen, Panebianco R, De Negri AM, Sadun F., Parisi V., Bandello B., Sadun Alfredo A., Carelli V., Yu-Wai-Man P.

Journal of Ophthalmologyhttps://doi.org/10.1016/j.ajo.2022.12.014

11) “Retinal and Visual Pathways involvement in carriers of Friedreich’s ataxia

Ziccardi L., Barbano L ., Antonelli G., Cioffi E., Di Renzo A., Gioiosa V., Marcotulli C., Grzybowski A., Casali C., Parisi V.

Diagnostics (Basel). 2022, 12(12), 3135; https://doi.org/10.3390/diagnostics12123135

1) Complement Mediators in Development to Treat Age-Related Macular Degeneration.

Nebbioso M., Franzone F., Lambiase A., Taurone S., Artico M., Gharbiya M., Greco A., Polimeni A.

Drugs Aging. 2022 Feb;39(2):107-118. doi: 10.1007/s40266-021-00914-x. Epub 2022 Jan 20.

2) SARS-CoV-2 infection after vaccination in Italian health care workers: a case report.

Cafiero C., Palmirotta R., Micera A., Ottaiano MP, Re A, Pedata F., Costagliola D., Ponticelli D,. Pisconti S., Schiavone B., Benincasa G.

Natl Acad Sci Lett. 2022 Mar 6 : 1–6. doi: 10.1007/s40009-022-01106-w PMID: 35283546

[Epub ahead of print]

3) Comment on Kopańska et al. Disorders of the Cholinergic System in COVID-19 Era- A Review of the Latest Research.

Cafiero C., Micera A., Re A., Schiavone B., Benincasa G., Palmirotta R.

Int J Mol Sci. 2022 Mar 4;23(5):2818. doi: 10.3390/ijms23052818.

4) Could Small Neurotoxins-Peptides be Expressed during SARS-CoV-2 Infection?

Concetta Cafiero , Alessandra Micera , Agnese Re , Loredana Postiglione , Andrea Cacciamani , Beniamino Schiavone , Giulio Benincasa , Raffaele Palmirotta

Curr Genomics. 2021 Dec 31;22(8):557-563. doi: 10.2174/1389202923666211221111527.

5) Biochemical Functions and Clinical Characterizations of the Sirtuins in Diabetes-Induced Retinal Pathologies”.

Taurone S., De Ponte C., Rotili D., De Santis E., Mai A., Fiorentino F., Scarpa S., Artico M., Micera A.

Int J Mol Sci. 2022 Apr 6;23(7):4048. doi: 10.3390/ijms23074048.

6) “Ocular surface toll like receptors in ageing”.

Di Zazzo A., De Piano M., Coassin M., Mori T., Balzamino BO, Micera A.

BMC Ophthalmol. 2022 Apr 22;22(1):185. doi: 10.1186/s12886-022-02398-8.

7) “Oxidative stress and visual system: a review”.

Taurone S., Ralli M., Artico M., Madia V.N., Scarpa S., Nottola S.A., Maconi A., Betti M., Familiari P., Nebbioso M., Costi R., Micera A.

EXCLI J. 2022 Mar 1;21:544-553. doi: 10.17179/excli2022-4663. eCollection 2022.

8) “Nerve Growth Factor (NGF) as Partaker in the Modulation of UV-Response in Cultured Human Conjunctival Fibroblasts”.

Esposito G., Balzamino B.O., Rocco M.L., Aloe L., Micera A.

Int J Mol Sci. 2022 Jun 6;23(11):6337. doi: 10.3390/ijms23116337.

9) “Association between Vitamin D Receptor Gene Polymorphisms and Periodontal Bacteria: A Clinical Pilot Study”

Cafiero C., Grippaudo C., Dell’Aquila M., Cimmino P., D’Addona A., De Angelis P, Ottaiano M P, Costagliola D, Benincasa G., Micera A, Santacroce L., Palmirotta R.

Biomolecules. 2022 Jun 15;12(6):833. doi: 10.3390/biom12060833.

10) Tissue remodeling in adult vernal keratoconjunctivitis

Micera A., Di Zazzo A., De Piano M., Sharma S., Mori T., De Gregorio C., Coassin M., Ferndandes M.

Exp Eye Res. 2022 Dec;225:109301. doi: 10.1016/j.exer.2022.109301. Epub 2022 Nov 3.

11) ”The usefulness of lutein/trypan blue vital dye for the staining of corneal endothelium: a pilot study on DMEK pretreated tissues”.

Colabelli Gisoldi R., Lodato G., Balzamino B. O., Esposito G., Micera A., Pocobelli A.

Graefes Arch Clin Exp Ophthalmol. 2022 Nov 29;1-9. doi: 10.1007/s00417-022-05909-x. Online ahead of print.

12) “Circulating and Salivary NGF and BDNF Levels in SARS-CoV-2 Infection: Potential Predictor Biomarkers of COVID-19 Disease-Preliminary Data”.

Biamonte F., Re A., Balzamino B.O., Ciasca G., Santucci D., Napodano C., Nocca G., Fiorita A., Marino M., Basile U., Micera A., Callà CAM.

J Pers Med. 2022 Nov 9;12(11):1877.doi: 10.3390/jpm12111877. J Pers Med. 36579579

1) Insulin-Degrading Enzyme Is a Non Proteasomal Target of Carfilzomib and Affects the 20S Proteasome Inhibition by the Drug.

Tundo G.R., Sbardella D., Oddone F., Grasso G., Marini S., Atzori M.G., Santoro A.M., Milardi D., Bellia F., Macari G., Graziani G., Polticelli F., Cascio P., Parravano M., Coletta M.

Biomolecules. 2022 Feb 16;12(2):315. doi: 10.3390/biom12020315.

2) “High glucose induces an early and transient cytoprotective autophagy in retinal Müller cells”.

Mecchia C., Palumbo, A. De Luca, D. Sbardella, A. Boccaccini, L. Rossi, M. Parravano, M. Varano, A. M. Caccuri.

Endocrine. 2022 May 25. doi: 10.1007/s12020-022-03079-8. Online ahead of print

3) “A novel and atypical NF-KB pro-inflammatory program regulated by a CamKII-proteasome axis is involved in the early activation of Muller glia by high glucose”

Sbardella D., Tundo G.R., Mecchia A., Palumbo C., Atzori M. G., Levati L., Boccaccini A., Caccuri A. M., Cascio P., Lacal P.M., Graziani G,. Varano M., Coletta M., Parravano M.

Cell Biosci. 2022 Jul 16;12(1):108. doi: 10.1186/s13578-022-00839-x

4) Choroidal vascularity index in eyes with central macular atrophy secondary to age-related macular degeneration and Stargardt disease.

Corbelli E., Sacconi R., Battista M., Bacherini D., Miere A., Borrelli E., Costanzo E., Vella G., Parravano M., Ziccardi L., Sodi A., Rizzo S., Souied E.H., Bandello F., Querques G.

Graefes Arch Clin Exp Ophthalmol. 2022 Jan 20. doi: 10.1007/s00417-021-05337-3. Online ahead of print.

5) “Branch retinal artery occlusion caught in the act by an optical coherence tomography angiography image: case report”

Scarinci F., Cacciamani A., Ripandelli G., Parravano M.

BMC Ophthalmol. 2022 Jul 14;22(1):303.doi: 10.1186/s12886-022-02517-5.

6) “Biopsychosocial Illness Model: From the Lung to the Eye”

Scarinci F., Parravano M., Patacchioli F. R.

J Clin Med. 2022 Jul 25;11(15):4298.doi: 10.3390/jcm11154298

7) “Multimodal Study of PRPH2 Gene-Related Retinal Phenotypes”

Antonelli G., Parravano M., Barbano L., Costanzoa E., Bertelli M., Medori M. C., Parisi V., Ziccardi L.

Diagnostics (Basel).2022 Jul 31;12(8):1851.doi: 10.3390/diagnostics12081851

8) “The Narrative Medicine Approach in the Treatment of Diabetic Macular Edema: An Italian Experience”

Midena E., Polo Cm Frizziero L., Marini M. G., Lattanzio R., Vadalà M., Pilotto E., Varano M.

Int J Environ Res Public Health. 2022 Jul 30;19(15):9367.doi: 10.3390/ijerph19159367

9) ”Cortisol awake response imbalance as an indicator of acute central serous chorioretinopathy: relationship with choriocapillaris and choroidal features”

Scarinci F., Patacchioli F. R., Costanzo E.M., Parravano M.

Front. Med., 30 November 2022Sec. Ophthalmology https://doi.org/10.3389/fmed.2022.1030352

10) “Short-term in vitro ROS detection and oxidative stress regulators in epiretinal membranes and vitreous from idiopathic vitreoretinal diseases”.

Balzamino B.O., Dinice L., Cacciamani A., re A., Scarinci F., Bruno L., Cosimi P., Micera A.

BioMed Research International, vol. 2022, Article ID 7497816, 12 pages, 2022. https://doi.org/10.1155/2022/7497816

11) “Morphological and biomolecular targets in Retina and Vitreous from Reelin-deficient mice (Reeler): potential implications for Age-related Macular Degeneration in Alzheimer’s Dementia”.

Balzamino B.O., Esposito G., Marino R., Calissano P., Latina V., Amadoro G., Keller F., Caccimani A., Micera A.

Front. Aging Neurosci., 16 November 2022 Sec. Alzheimer’s Disease and Related Dementias

https://doi.org/10.3389/fnagi.2022.1015359

12) “Middle-Inner Macular Layers Dysfunction in a Case of Stellate Foveomacular Retinoschisis Detected by Abnormal Multifocal Photopic Negative Response Recordings”.

Barbano L., Antonelli G., Parravano M., Costanzo E., Parisi V., Ziccardi L.

Diagnostics (Basel). 2022 Nov 10;12(11):2753.doi: 10.3390/diagnostics12112753.

13) “Biallelic Inactivating TUB Variants Cause Retinal Ciliopathy Impairing Biogenesis and the Structure of the Primary Cilium”.

Ziccardi L., Niceta M., Stellacci , Ciolfi A., Tatti M., Brusselles A., Mancini C., Barbano L., Cecchetti S., Costanzo E., Cappa M., Parravano M., Varano M., Trataglia M., Cordeddu V.

J Mol Sci 2022 Nov 24;23(23):14656. doi: 10.3390/ijms232314656.

14) “Morpho-Functional Macular Assessment in a Case of Facioscapulohumeral Muscular Dystrophy: Photoreceptor Degeneration as Possible Cause for Reduced Visual Acuity over Three Years of Follow-Up”.

Parravano M., Costanzo E., Barbano L., Viggiano P., De Geronimo D., Antonelli G., Parisi V., Varano M., Ziccardi L.

Diagnostics2022, 12(12), 2977;https://doi.org/10.3390/diagnostics12122977

15) “A novel algorithm for the evaluation of corneal nerve beadings by in vivo confocal microscopy in patients with type 1 diabetes mellitus”

Abicca I., Giannini D., Gilardi M., Roszkowska A.M., Parravano M., Picconi F., Frontoni S., Schiano-Lomoriello D.

Front Med (Lausanne) 2022 May 12;9:897259.doi: 10.3389/fmed.2022.897259. eCollection 2022.

16) ”Effects of circadian rhythm disruption on retinal physiopathology: considerations from a consensus of experts”

Parravano M., Eandi C.M., Figus M., Lupidi M., Menchini F., Nicolo’ M., Parisi V., Toto L., Viola F., Vujosevic S., Querques G.

Eur J Ophthalmol 2022 Sep;32(5):2489-2493.doi: 10.1177/11206721221106149. Epub 2022 Jun 3.

17) “Author Response: Relationship of Choroidal Vasculature and Choriocapillaris Flow With Alterations of Salivary α-Amylase Patterns in Central Serous Chorioretinopathy”.

Scarinci F., Patacchioli F.R., Costanzo E., Parravano M.

Invest Ophthalmol Vis Sci. 2022 Jun 1;63(6):10. Doi:10.1167/iovs.63.6.10

1)“Label-free determination of diffusion coefficients at the nanoscale through modelling of the Surface Plasmon Resonance signal”

Zingale G A, Pandino I, Calacagno D, Perina M L, Tuccitto N, Grasso G 

PLoS One. 2025 Jan 7;20(1):e0312594. https://doi.org/10.1371/journal.pone.0312594 

 

2)”Preservative-Free Bimatoprost 0.01% Ophthalmic Gel for Glaucoma Therapy: A Phase III Randomized Controlled Trial” 

Muñoz-Negrete Francisco J , Tpouzis F, Oddone F, Nissle S, Rokicki D, Januleviciene I, Harasymowycz P, Stalmans I.  

J Glaucoma. 2024 Jun 1;33(6):422-430. https://doi.org/10.1097/IJG.0000000000002371

 

3)”Safety and Longevity of Intraocular Pressure Control After Bimatoprost Implant Administration: Interim Analysis of a Phase 3b Clinical Trial (TRITON)” 

Silverstein S M, Oddone F, Kolko M, Brinkmann C K, Christie W C, Bicket A K, Gous P NJ, Luebke J, Maram J, Nguyen A, Craven E R, Pu Y, Jiao J, BejanianM, Robinson MR, TRITON Studt Group 

Drugs. 2025 Apr;85(4):557-570. https://doi.org/10.1007/s40265-025-02154-4

 

4)“A phase III study comparing preservative-free latanoprost eye drop emulsion with preserved latanoprost in open-angle glaucoma or ocular hypertension” 

Baudouin C, Stalmans I, Bourne R, Larrosa JM, Schmickler S, Seleznev A, Oddone F, Phase III Study Group 

Eye (Lond). 2025 Feb 25. https://doi.org/10.1038/s41433-025-03646-z

 

5)“Italian glaucoma virtual clinics: Developing a consensus for remote patient management” 

Matarazzo F, Cutolo CA, Rabiolo A, Figus M, Fea A, Gandolfi S, Gizzi C, Manni G, Marchini G, Montesano G, Nucci C, Passaro ML, Romano D, Rossetti L, Sacchi M, Tanga L, Traverso CE, Triolo G, Virgili G, Oddone F, Costagliola C.  

Acta Ophthalmol. 2025 Mar 17.   https://doi.org/10.1111/aos.17484

  

6)”Vascular Density and Retinal Structure Relationships Across Sectors and Regions of the Optic Nerve in Patients With Primary Open Angle Glaucoma” 

Ritzer L, Harris A, Arciero J, Siesky B, Fry B, Januleviciene I, Oddone F, Carnevale C, Eckrt G, Verticchio Vercellin A. 

J Glaucoma. 2025 Apr 1;34(4):267-274. https://doi.org/10.1097/IJG.0000000000002536

7)“Medical and surgical treatment management in open angle glaucoma patients of Asian descent: A narrative review” 

Belamkar A V, Harris A, Wirotsko B, Rowe L, Oddone F, Carnevale C, Verticchio Vercelli A, Kanwar K, Wood K, Fabczak-Kubicka A, Siesky B,  

Eur J Ophthalmol. 2025 May 19:11206721251340435. https://doi.org/10.1177/11206721251340435 

8)“Efficacy and Safety of XEN63 Gel Stent Implant over 6 Months for Treatment of Glaucoma” 

Sacchi M, Giammaria S, Roberti G, Tomaselli D, Monsellato G, Agnifili L, Posarelli C, Abbruzzese G, Ronchi L, Tatti F, Dore S, Giannaccare G, Nucci P, Pinna A, Figus M, Oddone F. 

J Clin Med. 2025 Apr 28;14(9):3036. https://doi.org/10.3390/jcm14093036 

9)”Artificial intelligence for glaucoma” 

Vemulapalli K, Gandhewar R, Safitri A, Ng S M, Michelessi ;, Azuara-Blanco A, Liu S H, Virgili G, Hu K. 

Cochrane Database Syst Rev. 2025 Jun 17;6(6):CD016114. https://doi.org/10.1002/14651858.cd016114 

1)“A Pilot Case Series on the Use of a Large Mushroom-Shaped Corneal Graft for the Surgical Management of Post-Penetrating Keratoplasty Ectasia and Endothelial Failure “

Moramarco A, Fontana L, Di Geronimo N, Rapezzi G, Savini G, Viola P, Mete M, Romano V.

J Clin Med. 2025 Jan 8;14(2):343. https://doi.org/10.3390/jcm14020343

 

2)”Comparison of intraocular lens power formulas for negative diopter intraocular lens implantation for high myopia”

Whang WJ, Koh K, Hoffer K J,  Schiano Lomoriello D, Lupardi E, Taroni L, Tchah H, Savini G.

J Cataract Refract Surg. 2025 Feb 1;51(2):119-125. https://doi.org/10.1097/j.jcrs.0000000000001569

 

3)“The Influence of Anterior Chamber Depth on the Calculation of Piggyback Intraocular Lenses”

Buonsanti D, Hoffer K J, Coutinho C P, Savini G.

Am J Ophthalmol. 2025 Apr:272:161-165. https://doi.org/10.1016/j.ajo.2025.01.013

  

4)”Repeatability and reproducibility of a new spectral-domain optical coherence tomography biometer and agreement with swept-source optical coherence tomography based biometer”

Li X, Lei C S, Ning R, Liu L, Chen A, Yang X, Savini G, Schiano Lomoriello D, Zhou X, Huang J.

Eye Vis (Lond). 2025 Feb 1;12(1):6. https://doi.org/10.1186/s40662-024-00422-0

  

5)“Influence of preoperative variables on the 3-month functional outcomes of the Vivity extended depth-of-focus intraocular lens: a prospective case series”.

Savini G, Galzignato A, Coutinho C P, Huang J, Wu Y, Barboni P, Dias J M, Ribeiro F J, Schiano Lomoriello D.

Eye Vis (Lond). 2025 Feb 2;12(1):8. https://doi.org/10.1186/s40662-024-00424-y

6)“Which Test Is Best: Evaluation of Traditional and Contemporary Statistical Tests for Analysis of Spherical Equivalent Prediction Error”

Cannon N T, Savini G, Pantanelli S M, Hoffer K, Aristodemou P, Riaz K, Murphy D, Griffini D, Berry C, Debellemanière G, Gauvin M, Wallerstein A, Whang W J, Koh K, Negishi K, Hayashi K, Hipolito-Fernandes D, Cooke D L.

Am J Ophthalmol 2025 Feb 7:273:33-42. https://doi.org/10.1016/j.ajo.2025.01.022

 

7)”Repeatability of automatic measurements by a new spectral domain optical coherence biometer and agreement with a validated biometer”

Grendele A, Galzignato A, Hoffer K J, Coutinho C P, Calossi F, Schiano Lomoriello D, Savini G.

J Cataract Refract Surg 2025 Mar 10. https://doi.org/10.1097/j.jcrs.0000000000001650

 

8)“Evaluation of a New Fully Automatic OLCR Biometer: Repeatability, Reproducibility, and Agreement with an SS-OCT Biometer” 

Chak Seng Lei, Xinning Yang, Rui Ning, Jinxuan Xiahou , Xinyu Jiang, Savini G, Schiano Lomoriello D, Xingtao Zhou, Kexin Li, Jinhai Huang 

Ophthalmol Ther. 2025 May;14(5):1097-1109. https://doi.org/10.1007/s40123-025-01120-3 

 9)“Optical confirmation by a thick-lens formula of the optimized A-constant (as calculated by a thin-lens formula) of a new intraocular lens”. 

Savini G, Nicolosi D, Hoffer K J, Coutinho C P, Curatolo M C, Schiano Lomoriello D. 

J Cataract Refract Surg. 2025 Apr 10. https://doi.org/10.1097/j.jcrs.0000000000001671 

 

10)“IOL Power Calculation Project: Accuracy of 36 Formulas”. 

Voytsekhivskyy O V, Hoffer K J, Cooke D, Savini G. 

Am J Ophthalmol. 2025 May 12:277:45-56. https://doi.org/10.1016/j.ajo.2025.05.004 

 

11)”Comparison of IOL formula accuracy for eyes with prior scleral buckle surgery”. 

Kong A W, Jeon M J, Lin S R, Bartlett J D, McCannel C A, Hoffer K J, Savini G, Nejad M. 

J Cataract Refract Surg. 2025 Jun 9. https://doi.org/10.1097/j.jcrs.0000000000001715 

 

12)“Machine Learning Applied to Visual Fields of Dominant Optic Atrophy Patients”. 

Coutinho C P, Zanchetta F, Carbonelli M, Battista M, Galzignato A, La Morgia C, Amore G, Romagnoli M, Savini G, Brotto L, Nucci P, Caporali L, Bandello F, Carelli V, Cascavilla M L, Barboni P. 

Transl Vis Sci Technol. 2025 Jun 2;14(6):20. https://doi.org/10.1167/tvst.14.6.20 

 

13)“Theoretical Influence of segmented axial length on IOL Power calculation in short eyes”. 

Savini G, Hoffer K J, Nicolosi P D, Cooke D, Coutinho C P, Grendele A, Schiano Lomoriello D. 

Journal of Cataract & Refractive Surgery http://dx.doi.org/10.1097/j.jcrs.0000000000001711 

 

14)“Normative Values on Stromal Curvature, Power and Corneal-Stromal Curvature Ratios From a Hybrid AS-OCT” 

Wandelstein J A, Grendele A, Langenbucher A, Galzignato A, Coutinho C P, Pantanelli S, Riaz K M, Savini G. Clin Exp Ophthalmol. 2025 May 22. https://doi.org/10.1111/ceo.14556 

15)”Precision of Corneal Aberrometric Measurements With a New Hybrid Device and Comparison With a Scheimpflug/Placido Topography in Different Grades of Keratoconus”. 

Rui Ning, Yizhou Yang, Huilin Xu, Kexin Li, Zheng Li, Yue Li, Savini G, Schiano Lomoriello D, Xingtao Zhou, Xiaoying Wang, Jinhai Huang 

J Refract Surg, 2025 May;41(5): e460-e471. https://doi.org/10.3928/1081597x-20250401-03 

 

16)“Comparison of Anterior Segment Measurements With a New Swept-source Optical Coherence Tomography Biometer and a Scheimpflug-Placido Topographer”. 

Chak Seng Lei, Xin Li, Huilin Xu, Rui Ning, Yiran Wang, Giacomo Savini, Domenico Schiano-Lomoriello, Xingtao Zhou, Kexin Li, Jinhai Huang 

J Refract Surg. 2025 May;41(5): e413-e420. https://doi.org/10.3928/1081597x-20250317-03 

1)”Type 3 Macular Neovascularization in Age-related Macular Degeneration: Baseline Predictors of 3-Year Macular Atrophy Development”

Sacconi R, Forte P, Corradetti G, Costanzo E, Capuano V, Bousquet E, Beretta F, Iannuzzi S, Polito M S, Nicolò M, Parravano M, Souied E, Sarraf D, Sadda S V, Bandello F, Querques G.

Ophthalmol Retina. 2024 Nov 19:S2468-6530(24)00541-4.

https://doi.org/10.1016/j.oret.2024.11.011

2)“Faricimab versus the standard of care for neovascular age-related macular degeneration in Italy: an indirect treatment comparison”

Galeone C, Turati F, Nicolò M, Parravano M, Vujosevic S, Bianchino L, Sicari E, Lanzetta P.

Drug Target Insights. 2024 Dec 12:18:105-111. https://doi.org/10.33393/dti.2024.3213

 

3)”Microcystoid Macular Edema in Epiretinal Membrane: Not a Retrograde Maculopathy”

Govetto A, Francone A, Luccini S, Garavaglia S, Carini E, Virgili G, Radice P, Vogt D, Edwards M, Spaide R F, Romano M R.

Am J Ophthalmol. 2025 Apr:272:48-57. https://doi.org/10.1016/j.ajo.2024.12.027

 

4)“Real-world evidence of anti-VEGF therapies in patients with neovascular age-related macular degeneration in Italy: The RADIANCE study”

Parravano M, Viola F, Nicolò M, Vujosevic S, Bianchino L, Sicari E, Villa G, Lanzetta P.

Eur J Ophthalmol. 2025 Feb 3:11206721241310628. https://doi.org/10.1177/11206721241310628

 

5)”Prevalence of dry eye disease among children: a systematic review and meta-analysis”

Zou Y, Li D, Virgili G, Condon N, Piyassena P, PrakalapakomS G, Zhang R, Zhao Z, Fai Chan V, Yu M.

BMJ Open Ophthalmol. 2025 Feb 19;10(1):e002014. https://doi.org/10.1136/bmjophth-2024-002014

 

6)”Retinal detachment incidence in refractive lens exchange versus cataract surgery: uncommon versus rare – systematic review and meta-analysis”

Passaro M L, Kilic D, Virgili G, Romano V, Lucenteforte E, Dick B, Taneri S.

Br J Ophthalmol. 2025 Feb 27:bjo-2024-326592. https://doi.org/10.1136/bjo-2024-326592

 

7)”Retinal Dystrophies Associated with Mutations in the RP1Gene: Genotype-Phenotype Correlations”

Spagnuolo V, Piergentili M, Passerini I, Murro V, Mucciolo D P, Giorgio D, Maccari M, Pelo E, Biagini I, Giansanti F, Virgili G, Sodi A.

Curr Issues Mol Biol. 2025 Mar 20;47(3):212. https://doi.org/10.3390/cimb47030212

7)“Real-World Intravitreal Aflibercept 2 mg Treatment of Macular Oedema Secondary to Retinal Vein Occlusion in Italy: 24-Month Results from the AURIGA Observational Study” 

Grassi M O, Russo A, Vadalà M, Allmeier H, Machewitz T, Varano M, AURIGA Study Investigators 

Ophthalmologica. 2025 Apr 9:1-14. https://doi.org/10.1159/000545534 

 

8)“Comparison of Methods to Deliver Mitomycin C in Trabeculectomy Surgery: A Systematic Review and Meta-Analysis” 

Ghilardi A, Fan S, Mercieca K, Virgili G, De Cillà S, Rabiolo A.  

 Ophthalmol Glaucoma. 2025 Apr 19:S2589-4196(25)00072-9. https://doi.org/10.1016/j.ogla.2025.04.004 

 

9)“Femtosecond laser-assisted in situ keratomileusis for the correction of residual ametropia after penetrating keratoplasty: 1-year follow-up” 

Mucciolo D P, Albani G, Terracciano L, Branchetti M, Luchetti L, Murro V, Virgili G, Giansanti F.  

Front Ophthalmol (Lausanne). 2025 Apr 11:5:1562555. https://doi.org/10.3389/fopht.2025.1562555 

 

10)“Evaluating the burden of caregivers of patients with visual impairment: a multicenter pilot study in Italian visual rehabilitation centers” 

Virgili G, Ferron F, Bartolomei F, Van Nispen R, Costanzo E, Ciaffoni G L, Rellini E, Turco S, Piepoli M, Di Pietro S, Fortini S.  

Front Public health, 06 June 2025 Sec. Public Mental Health Volume 13, 2025  

https://doi.org/10.3389/fpubh.2025.1530172 

 

11)“Geographic Atrophy and Peripheral Atrophy: Quantitative Analysis with Ultra-Widefield Autofluorescence” 

De Geronimo D, Parravano M, Sacconi R, Costanzo E, Varano M, Querques G.  

Ophthalmologica. 2025 Apr 8:1-7. https://doi.org/10.1159/000544958 

 

12)“Behçet’s disease: A review of the ophthalmologic findings reported in Behçet’s original descriptions” 

Accorinti M, Gilardi M, Cecere M, Ohno S, De Geronimo D.  

Saudi J Ophthalmol. 2025 Feb 14;39(1):41-46. https://doi.org/10.4103/sjopt.sjopt_216_24 

 

13)”Updates on novel and traditional OCT and OCTA biomarkers in nAMD” 

Crincoli E, Parravano M, Sacconi R, Costanzo E, Polito M S, Ferro Desideri L, Querques G.  

Eye (Lond). 2025 Jun;39(9):1662-1672. https://doi.org/10.1038/s41433-025-03801-6 

 

14)”Evidence and Consensus-Based Imaging Guidelines in Multifocal Choroiditis With Panuveitis and Punctate Inner Choroiditis-Multimodal Imaging in Uveitis (MUV) Taskforce Report 5” 

Gangaputra S, Agarwal A, Ossewaarde-van Norel J, Tsui E, E Thoren J, De-la-Torre A, Altraweel M, Biswas J, Sadda S, Invernizzi A, Agrawal R, Shanta J G, Accorinti M, Fawzi A, Jabs D A, Sarraf D, Gupta V, Multimodal Imaging in Uveitis (MUV) Task force 

Am J Ophthalmol. 2025 Apr 25:276:272-285. https://doi.org/10.1016/j.ajo.2025.04.018 

1)“Internal Limiting Membrane Flaps in Macular Hole Surgery: A Systematic Review and Individual Participant Data Meta-analysis”

Tzoumas N, MCNally T W, The B L, Zaman M, Yorston D, Lois N, Chaudhary V, Steel D H, ILM Flap Study Group

Ophthalmol Retina. 2025 Feb 7:S2468-6530(25)00055-7.  https://doi.org/10.1016/j.oret.2025.02.003

 

2)”Comparing the Efficiency of Valved Trocar Cannulas for Pars Plana Vitrectomy” 

   Rossi T, Querzoli G, Angelini G B, Pellizzaro C, Santoro V, Rosari G, Parravano M, Romano M R.    Bioengineering (Basel). 2025 Apr 19;12(4):431. https://doi.org/10.3390/bioengineering12040431 

 

3)Comparing the Efficiency of Fluid Infusion Systems for Pars Plana Vitrectomy” 

 Rossi T, Querzoli G, Angelini G B, Santoro V, Pellizzaro C, Steel D H, Parravano M, Romano M R. 

Transl Vis Sci Technol. 2025 May 1;14(5):10. https://doi.org/10.1167/tvst.14.5.10 

1)Universally Present and Co-Localize With Intraretinal Fluid in Diabetic Macular Edema”

Midena E, Frizziero L.

Invest Ophthalmol Vis Sci. 2025 Feb 3;66(2):59. https://doi.org/10.1167/iovs.66.2.59

 

2)”Disorganisation of inner retinal layers in diabetic macular oedema: is it time to standardise this OCT biomarker?”

Danieli L, Midena G, Frizziero L, Midena E.

Br J Ophthalmol. 2025 Feb 27:bjo-2024-326843. https://doi.org/10.1136/bjo-2024-326843

 

3)”Neurofibromatosis type 1 (NF1)-related ocular signs: new insights on their prevalence, incidence and genotype-phenotype correlation in NF1 children”

Midena E, Cosmo E.

Am J Ophthalmol. 2025 Mar 5:S0002-9394(25)00110-2. https://doi.org/10.1016/j.ajo.2025.02.044

 

4)“Hyperreflective retinal foci: definition and role of an invaluable OCT sign” 

 Frizziero L, Midena G, Danieli  L, Torresin T, Perfetto A, Parrozzani R, Pilotto  E, Midena E 

 J Clin Med. 2025 Apr 27;14(9):3021. https://doi.org/10.3390/jcm14093021 

 

5)”Artificial intelligence-based assessment of imaging biomarkers in epiretinal membrane surgery” 

 Mariotti C, Mangoni L, Mui A, Fella M, Mogetta V, Bongiovanni G, Rizzo C, Chhablani J, Midena E, Lupidi M 

 Eur J Ophthalmol. 2025 Apr 27:11206721251337139. https://doi.org/10.1177/11206721251337139 

Abagnale C, Di Renzo A, Giuliani G, Sebastianelli G, Casillo F, Ziccardi L, Parisi V, Di Lorenzo C, Serrao M, Caramia F, Di Piero V, Coppola G.

J Headache Pain. 2025 Jan 15;26(1):12. https://doi.org/10.1186/s10194-024-01920-1

2)“Assessment of hypothalamic macrostructure in episodic cluster headache: a volumetric segmentation MRI study” 

  Chiffi D, Di Renzo A, Giuliani G, Abagnale C, Altieri M, Sebastianelli G, Casillo F, Di Piero V, Coppola G, Caramia F.  

  Radiol Med. 2025 Jun 27. https://doi.org/10.1007/s11547-025-02041-8 

1)”VEGFR3 pathway in corneal transplantation”

Laborante M, Micera M, Gaudenzi D, De Luca A, De Gregorio C, Cutrupi F, Esposito G, Balzamino BO, Laborante A, Coassin M, Di Zazzo A.

Acta Ophthalmol. 2025 Feb 6. https://doi.org/10.1111/aos.17457

2)”Oncological Treatment Adverse Reaction Prediction: Development and Initial Validation of a Pharmacogenetic Model in Non-Small-Cell Lung Cancer Patients”

Cafiero C, Palmirotta R, Martinelli C, Micera A, Giacò L, Persiani F, Morrione A, Pastore C, Nisi C, Modoni G, Galeano T, Guarino T, Foggetti I, Nisticò C, Giordano A, Pisconti S.

Genes (Basel). 2025 Feb 24;16(3):265. https://doi.org/10.3390/genes16030265

 

3)”Acute targeting of N-terminal tau protein has long-lasting beneficial effects in Tg2576 APP/Aβ mouse model by reducing cognitive impairment, cerebral Aβ-amyloidosis, synaptic remodeling and microgliosis later in life” 

 Latina V, De Introna M, Malerba F, Florio R, Omar B O, Di Natale G, Sciacca MFM, Pappalardo G, Micera A, Pignataro A, Calissano P, Amadoro G. 

 Acta Neuropathol Commun. 2025 May 29;13(1):121. https://doi.org/10.1186/s40478-025-02022-y 

 

4)“Ceruloplasmin and Ferritin Changes in Ocular Fluids from Patients with Vitreoretinal Diseases: Relation with Neuroinflammation and Drusen Formation.” 

Esposito, G.; Cosimi, P.; Balzamino, B.O.; Bruno, M.; Squitti, R.; 

Dinice, L.; Scarinci, F.; Rongioletti, M.C.A.; Cacciamani, A.; Micera, A.  

Int. J. Mol. Sci. 2025, 26, 6307. https://doi.org/10.3390/ ijms26136307 

1)“Nitrite binding to myoglobin and hemoglobin: Reactivity and structural aspects”

Ascenzi P, De Simone G, Zingale GA, Coletta M.

J Inorg Biochem. 2025 Apr:265:112829. https://doi.org/10.1016/j.jinorgbio.2025.112829

2)“Label-free determination of diffusion coefficients at the nanoscale through modelling of the Surface Plasmon Resonance signal”

Zingale G A, Pandino I, Calacagno D, Perina M L, Tuccitto N, Grasso G

PLoS One. 2025 Jan 7;20(1):e0312594. https://doi.org/10.1371/journal.pone.0312594

3)“Broad-Spectrum Diffusion Coefficient Measurements via Surface Plasmon Resonance: From Thermodynamics to Protein Conformational Disorders”  

Basile G S, Calcagno D, Tuccitto N, Sbardella D, Grasso G. 

Chemphyschem. 2025 Jun 29:e2500138. https://doi.org/10.1002/cphc.202500138 

1)“RETINAL DISPLACEMENT AFTER IDIOPATHIC MACULAR HOLE SURGERY: Layer by Layer Analysis”

Rossi T, Querzoli G, Ripandelli G, Placentino L, Parravano M, Steel D H, Romano M R,

Retina. 2025 Mar 1;45(3):410-419. https://doi.org/10.1097/IAE.0000000000004352

 2)“Profiling of the Peripheral Blood Mononuclear Cells Proteome by Shotgun Proteomics Identifies Alterations of Immune System Components, Proteolytic Balance, Autophagy, and Mitochondrial Metabolism in Glaucoma Subjects” 

Giammaria S, Pandino I, Zingale G A, Atzori M A, Cavaterra D, Cecere M, Michelessi M, Roberti G, Tanga L, Carnevale C, Verticchio Vercellin A, Siesky B, Harris A, Grasso G, Bocedi A, Coletta M, Tundo G R, Oddone F, Sbardella D. 

ACS Omega. 2025 Apr 9;10(15):14866-14883. https://doi.org/10.1021/acsomega.4c10035 

(Lavoro in condivisione tra la UR di Glaucoma e la UR Laboratorio di Proteomica)